维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Dubinsky MC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease 显示文摘	Dubinsky MC Wang D Picomell Y	2007	Inflamm Bowel Dis2007，13，：	1
2	What is the role of serological markers in the diag- nosis of IBD? 显示文摘	Dubinsky MC	2008	Inflamm Bowel Dis2008，14，2：	1
3	Pharmacogenetics and metabolite measurement for 6-mercaptopurine therapy in flammatory bowel disease显示文摘	DUBINSKY MC LAMOTHE S YANG HY	2000	Gastroenterology2000，118，：	1
4	Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease 显示文摘	Dubinsky MC Ofman JJ Urman M Targan SR Seidman EG	2001	Am J Gastroenterol2001，96，3：	1
5	Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease显示文摘	Dubinsky MC Lamothe S Yang HY	2000	Gastroenterology2000，118，4：	1
6	Increased immune re- activity predicts aggressive complicating Crohn's disease in children 显示文摘	Dubinsky MC Kugathasan S Mei L	2008	Clin Gastroenterol Hepatol2008，6，10：	1
7	Increased immune reactivity predicts aggressive complicating Crohn's disease in children显示文摘	Dubinsky MC Kugathasan S Mei L	2008	Clin Gastroenterol Hepatol2008，6，10：	1
8	显示文摘	Dubinsky MC Seidman EG		Current Opinion in Gastroonterdogy0，16，4：	1
9	Severe Colitis in Children显示文摘	Kugathasan S Dubinsky MC Keljo D	2005	J Pediatr Gastroenterol2005，41，4：	1
10	Correlation of analgesia with levels of tilidine and a biologically active metabolite in rat plasma and bain 显示文摘	DUBINSKY B CREW MC MELGAR MD	1975	Biochem Pharmacol1975，24，2：	1
11	Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease显示文摘	Dubinsky MC Lamothe S Yang HY	2000	Gastroenterology2000，118，4：	1
12	Pharmacogenomics and metabolite measurement for 6 - mereaptopurine therapy in inflamma- tory bowel disease 显示文摘	Dubinsky MC Larnothe S Yang HY	2000	Gastroenterology2000，118，：	1
13	Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease显示文摘	Dubinsky MC Mei L Friedman M		0，，8：	1
14	The impact of ulcerative colitis on patients : lives compared to other chronic diseases:a patient survey显示文摘	Rubin DT Dubinsky MC Panaccione R	2010	Dig Dis Sci2010，55，4：	1
15	Phar macogenomicsand metabolite measurement for 6 mercaptopurine therapy in inflammatory bowel dis ease显示文摘	Dubinsky MC Lamothe S Yang HY	2000	Gastroenterology2000，18，4：	1
16	6 - MP metabolite profiles provide a biochemical explanation for 6 - MP resistance in patients with inflammatory bowel disease 显示文摘	Dubinsky MC Yang H Hassard PV	2002	Gastroenterology2002，122，：	1
17	Pharmaeogenom- ics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease显示文摘	Dubinsky MC Lamothe S Yang HY	2000	Gastroenterology2000，118，4：	1
18	6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease显示文摘	Dubinsky MC Yang H Hassard PV	2002	Gastroenter- ology2002，122，4：	1
19	Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta analysis显示文摘	Khan KJ Dubinsky MC Ford AC	2011	Am J Gastroenterol2011，106，4：	1
20	IL-23 receptor(IL-23R)gene protects against pediatric Crohn's disease显示文摘	Dubinsky MC Wang D Picornell Y	2007	Inflamm BowelDis2007，13，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示